cyt006-angqb
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2004 (NCT00500786)
Timeline
Indications
Mechanism of action
- AngiotensinogenImmunity, active
AGT immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cyt006-angqb
- cyt006-angqb
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00710372 | Phase 2 | Jun 1, 2008 | Cytos Biotechnology AG |
| NCT00701649 | Phase 2 | Mar 1, 2008 | Cytos Biotechnology AG |
| NCT00500786 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2004 | Cytos Biotechnology AG, Parexel |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cytos Biotechnology AG | For profit | 3 | 3 | 1 | 2004 |
| Parexel | For profit | 1 | 0 | 1 | 2004 |
2 organizations
Page 1 / 1